Osaic Holdings’s Sunshine Biopharma SBFM Stock Holding History

Osaic Holdings’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4	Buy	+2	New	+$13	﹤0.01%	7961
2026 Q1	–	Sell	-15	Closed	-$177	–	7783
2025 Q4	$186	Hold	15	–	–	﹤0.01%	7590
2025 Q3	$225	Hold	15	–	–	﹤0.01%	7683
2025 Q2	$218	Buy	+15	New	+$219	﹤0.01%	7491
2025 Q1	–	Hold	0	–	–	–	7405
2024 Q4	–	Hold	0	–	–	–	7358
2024 Q3	–	Hold	0	–	–	–	7375
2024 Q2	–	Hold	0	–	-$4	–	7595
2024 Q1	–	Hold	0	–	–	–	7163
2023 Q4	–	Hold	0	–	–	–	7029
2023 Q3	–	Sell	-1	Closed	-$8.95K	–	6807
2023 Q2	$5.92K	Buy	+1	New	+$12.1K	﹤0.01%	6228
2023 Q1	–	Hold	0	–	–	–	6331
2022 Q4	–	Hold	0	–	–	–	6422
2022 Q3	–	Hold	0	–	–	–	6387
2022 Q2	–	Hold	0	–	–	–	6250

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SFG

Strive Financial Group Carmel, Indiana $230M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Osaic Holdings's SBFM Position: Q2 2026 in Review

Osaic Holdings opened a new position in Sunshine Biopharma (SBFM) in Q2 2026: 2 shares worth $4. The stake represents ﹤0.01% of the portfolio and ranks #7961 among its holdings. This is a return to the name: Osaic Holdings previously reported a position in SBFM as recently as Q4 2025.

Osaic Holdings first reported a position in SBFM in Q2 2023 and has held it in 5 quarters since. The position peaked at $5.92K in Q2 2023. 9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

Osaic Holdings held 2 shares of Sunshine Biopharma worth $4 as of Q2 2026.
Sunshine Biopharma was a new Osaic Holdings position in Q2 2026.
Sunshine Biopharma made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7961 holding.
Osaic Holdings first reported a position in Sunshine Biopharma in Q2 2023 and has held it in 5 quarters since.
Osaic Holdings's Sunshine Biopharma position peaked at $5.92K in Q2 2023.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.